Akebia Therapeutics (AKBA) EBT Margin Growth (1y) (2018 - 2026)
Akebia Therapeutics (AKBA) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Akebia Therapeutics | 244.72 Mn | 89.17 Mn | 38.70 Mn | -1,839.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,839.00 |
| Mar 31, 2026 | -2,733.00 |
| Dec 31, 2025 | 2,955.00 |
| Sep 30, 2025 | 5,551.00 |
| Jun 30, 2025 | 2,006.00 |
| Mar 31, 2025 | 6,582.00 |
| Dec 31, 2024 | -5,014.00 |
| Sep 30, 2024 | -1,908.00 |
| Jun 30, 2024 | 16.00 |
| Mar 31, 2024 | 1,202.00 |
| Dec 31, 2023 | 849.00 |
| Sep 30, 2023 | 7,332.00 |
| Jun 30, 2023 | -4,465.00 |
| Mar 31, 2023 | 8.19 Mn |
| Dec 31, 2022 | -5,220.00 |
| Sep 30, 2022 | 1,033.00 |
| Jun 30, 2022 | 17,988.00 |
| Mar 31, 2022 | -8.18 Mn |
| Dec 31, 2021 | 44,482.00 |
| Sep 30, 2021 | 28,162.00 |